Viewing Study NCT05019703


Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2025-12-29 @ 5:21 AM
Study NCT ID: NCT05019703
Status: RECRUITING
Last Update Posted: 2025-10-09
First Post: 2021-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module